Year |
Citation |
Score |
2019 |
Pradhan AM, Park L, Shaya FT, Finkelstein J. Consumer Health Information Technology in the Prevention of Substance Abuse: Scoping Review. Journal of Medical Internet Research. 21: e11297. PMID 30698526 DOI: 10.2196/11297 |
0.318 |
|
2016 |
Rodriguez de Bittner M, Chirikov VV, Breunig IM, Zaghab RW, Shaya FT. Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling. Journal of the American Pharmacists Association : Japha. PMID 27769877 DOI: 10.1016/J.Japh.2016.08.010 |
0.324 |
|
2015 |
Kountz DS, Shaya FT, Gradman AH, Puckrein GA, Kim MH, Wilbanks J, Stevenson JG, Larsen DL, Wysong M, Chirikov V, Pan WT, Xu L. A Call for Appropriate Evidence and Outcomes-Based Use and Measurement of Anticoagulation for Atrial Fibrillation: Moving the Population Towards Improved Health Via Multiple Stakeholders. Journal of Managed Care & Specialty Pharmacy. 21: 1034-8. PMID 26521115 DOI: 10.18553/Jmcp.2015.21.11.1034 |
0.343 |
|
2014 |
Breunig IM, Shaya FT, McPherson ML, Snitker S. Development of heart failure in Medicaid patients with type 2 diabetes treated with pioglitazone, rosiglitazone, or metformin. Journal of Managed Care & Specialty Pharmacy. 20: 895-903. PMID 25166288 DOI: 10.18553/Jmcp.2014.20.9.895 |
0.32 |
|
2014 |
Khanna N, Shaya F, Chirikov V, Steffen B, Sharp D. Dissemination and adoption of the advanced primary care model in the Maryland multi-payer patient centered medical home program. Journal of Health Care For the Poor and Underserved. 25: 122-38. PMID 24583492 DOI: 10.1353/Hpu.2014.0066 |
0.321 |
|
2013 |
Shaya FT, Chirikov VV, Bron M, Howard D, Foster C, Yan X, Khanna N, Warrington VO. Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy. Expert Review of Pharmacoeconomics & Outcomes Research. 13: 153-60. PMID 23402455 DOI: 10.1586/Erp.12.75 |
0.501 |
|
2013 |
Shaya FT, Chirikov VV, Daniel Mullins C, Shematek J, Howard D, Foster C, Saunders E. Social networks help control hypertension. Journal of Clinical Hypertension (Greenwich, Conn.). 15: 34-40. PMID 23282122 DOI: 10.1111/Jch.12036 |
0.3 |
|
2012 |
Breunig IM, Shaya FT, Scharf SM. Delivering cost-effective care for COPD in the USA: recent progress and current challenges. Expert Review of Pharmacoeconomics & Outcomes Research. 12: 725-31. PMID 23252355 DOI: 10.1586/Erp.12.69 |
0.357 |
|
2011 |
Shaya FT, Gbarayor CM, Laird A, Winston R, Saunders E. Diabetes knowledge in a high risk urban population. Ethnicity & Disease. 21: 485-9. PMID 22428355 |
0.752 |
|
2011 |
Johnson W, Shaya FT, Khanna N, Warrington VO, Rose VA, Yan X, Bailey-Weaver B, Mullins CD, Saunders E. The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population. Journal of Clinical Hypertension (Greenwich, Conn.). 13: 563-70. PMID 21806766 DOI: 10.1111/J.1751-7176.2011.00477.X |
0.484 |
|
2011 |
Shaya FT, Yan X, Johnson WR. Pms7 The Impact Of Rheumatoid Arthritis On Cardiovascular Morbidity In A High Risk Medicaid Population Value in Health. 14. DOI: 10.1016/J.Jval.2011.02.693 |
0.497 |
|
2011 |
Yan X, Shaya FT. Pcv63 The Impact Of Cardiovascular Disease Hospitalizations On Changes In Patient Adherence To Antihypertenisve Drugs In A Medicaid Population Value in Health. 14. DOI: 10.1016/J.Jval.2011.02.250 |
0.324 |
|
2010 |
Shaya FT, Yan X, Farshid M, Barakat S, Jung M, Low S, Fedder D. Social networks in cardiovascular disease management. Expert Review of Pharmacoeconomics & Outcomes Research. 10: 701-5. PMID 21155703 DOI: 10.1586/Erp.10.68 |
0.459 |
|
2010 |
Shaya FT, Yan X, Lin PJ, Simoni-Wastila L, Bron M, Baran R, Donner TW. US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes. Journal of Clinical Hypertension (Greenwich, Conn.). 12: 826-32. PMID 21029348 DOI: 10.1111/J.1751-7176.2010.00365.X |
0.48 |
|
2010 |
Bakhshai J, Bleu-Lainé R, Jung M, Lim J, Reyes C, Sun L, Rochester C, Shaya FT. The cost effectiveness and budget impact of natalizumab for formulary inclusion. Journal of Medical Economics. 13: 63-9. PMID 20028199 DOI: 10.3111/13696990903543424 |
0.319 |
|
2010 |
Onukwugha E, Loh F, Weir, Shaya F, Mullins C. Pcv66 Costs Associated With Discharges Against Medical Advice In A Cvd Population Value in Health. 13. DOI: 10.1016/S1098-3015(10)72785-6 |
0.315 |
|
2009 |
Shaya FT, Maneval MS, Gbarayor CM, Sohn K, Dalal AA, Du D, Scharf SM. Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population. Chest. 136: 405-11. PMID 19318663 DOI: 10.1378/Chest.08-2304 |
0.754 |
|
2009 |
Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population. Journal of the National Medical Association. 101: 34-9. PMID 19245070 DOI: 10.1016/S0027-9684(15)30808-7 |
0.753 |
|
2008 |
Shaya FT, Gu A, Yan X. Effect of Persistence with Drug Therapy On the Risk of Myocardial Re-infarction. P & T : a Peer-Reviewed Journal For Formulary Management. 33: 288-95. PMID 19561792 |
0.404 |
|
2008 |
Shaya FT, Flores D, Gbarayor CM, Wang J. School-based obesity interventions: a literature review. The Journal of School Health. 78: 189-96. PMID 18336677 DOI: 10.1111/J.1746-1561.2008.00285.X |
0.735 |
|
2007 |
Shaya FT, Samant N, Pradel F, Mullins CD, Scharf SM, Britt J. Health-related quality of life as a potential predictor in chronic obstructive lung disease patients. Expert Review of Pharmacoeconomics & Outcomes Research. 7: 129-35. PMID 20528439 DOI: 10.1586/14737167.7.2.129 |
0.725 |
|
2007 |
Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Digestive Diseases and Sciences. 53: 1020-4. PMID 17934828 DOI: 10.1007/S10620-007-9968-0 |
0.322 |
|
2007 |
Shaya FT, Gbarayor CM, Huiwen Keri Yang, Agyeman-Duah M, Saunders E. A perspective on African American participation in clinical trials. Contemporary Clinical Trials. 28: 213-7. PMID 17141575 DOI: 10.1016/J.Cct.2006.10.001 |
0.753 |
|
2007 |
Shaya FT, Wang J, Casciano M, Lee S, Levine A, Varghese R. Clinical and economic evaluation of olanzapine-fluoxetine HCl combination in the treatment of bipolar depression: A managed care approach Journal of Medical Economics. 10: 67-77. DOI: 10.3111/200710067077 |
0.343 |
|
2007 |
Shaya FT, Sohn K, Lee S, Bleu-Laine R, Lim J, Casciano M. Clinical and economic evaluation of exenatide for formulary decisions Journal of Medical Economics. 10: 529-537. DOI: 10.3111/13696990701748415 |
0.316 |
|
2007 |
Shaya F, Du D, Wang J, Akazawa M, Blanchette C, Mapel D. PRS12 PROPENSITY OF PRESCRIBING FLUTICASONE/SALMETEROL COMBINATION IN A HIGH RISK MEDICAID POPULATION Value in Health. 10: A180-A181. DOI: 10.1016/S1098-3015(10)69089-4 |
0.319 |
|
2007 |
Shaya F, Samant N, Saunders E. Pdb23 Impact Of Patient Education On Hba1C Reduction In Diabetic Patients With Concomitant Hypertension Value in Health. 10. DOI: 10.1016/S1098-3015(10)68740-2 |
0.713 |
|
2006 |
Shaya FT, Gbarayor C. Adjusting for risk and confounding in outcomes research. Expert Review of Pharmacoeconomics & Outcomes Research. 6: 109-10. PMID 20528544 DOI: 10.1586/14737167.6.2.109 |
0.754 |
|
2006 |
Shaya FT, Gbarayor CM. The case for cultural competence in health professions education. American Journal of Pharmaceutical Education. 70: 124. PMID 17332850 DOI: 10.5688/Aj7006124 |
0.753 |
|
2006 |
Samant N, Shaya F, Khoury AE. Pcv61 Determinants Of Adherence To Statins Ina Medicaid Managed Care Population Value in Health. 9. DOI: 10.1016/S1098-3015(10)64729-8 |
0.728 |
|
2006 |
Khoury AE, Shaya F, Samant N. Pcv60 Impact Of Adherence To Antihyperlipidemic Drugs On Total Pharmacy And Medical Costs Value in Health. 9. DOI: 10.1016/S1098-3015(10)64728-6 |
0.714 |
|
2006 |
Shaya F, Samant N, Khoury AE. Pcv9 Cardiovascular Risk Predicted By Adherence To Statins In A Medicaid Population Value in Health. 9. DOI: 10.1016/S1098-3015(10)64679-7 |
0.725 |
|
2006 |
Shaya FT, El Khoury AC, Samant ND, Scharf SM. Utilization of health care resources in a high-risk medicaid population with chronic obstructive pulmonary disease P and T. 31: 261-268. |
0.722 |
|
2005 |
Shaya FT, Klaskala W, Mullins CD. Review of cost-effectiveness studies of pegylated therapies for hepatitis C. Expert Review of Pharmacoeconomics & Outcomes Research. 5: 339-51. PMID 19807603 DOI: 10.1586/14737167.5.3.339 |
0.308 |
|
2005 |
Shaya FT, Samant N, Skolasky R, Saunders E. Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores. Expert Review of Pharmacoeconomics & Outcomes Research. 5: 625-32. PMID 19807588 DOI: 10.1586/14737167.5.5.625 |
0.719 |
|
2005 |
Shaya FT. Compliance with medicine. Ophthalmology Clinics of North America. 18: 611-7. PMID 16314223 DOI: 10.1016/J.Ohc.2005.07.005 |
0.334 |
|
2005 |
Shaya FT, Blume SW, Blanchette CM, Weir MR, Mullins CD. Selective cyclooxygenase-2 inhibition and cardiovascular effects: An observational study of a medicaid population Archives of Internal Medicine. 165: 181-186. PMID 15668364 DOI: 10.1016/J.Accreview.2005.03.007 |
0.302 |
|
2004 |
Shaya FT, Samant N. Formulary decision methodology in the context of health system costs and insurance trends. Expert Review of Pharmacoeconomics & Outcomes Research. 4: 595-7. PMID 19807530 DOI: 10.1586/14737167.4.6.595 |
0.714 |
|
2004 |
Shaya FT, Samant N. Cost studies in clinical trials. Expert Review of Pharmacoeconomics & Outcomes Research. 4: 591-4. PMID 19807529 DOI: 10.1586/14737167.4.6.591 |
0.704 |
|
2004 |
Shaya FT, Wong W, Shin JY, Martin L, Samant N. Formulary decision-making considerations: COX-2 inhibitors. Managed Care Interface. 17: 29-36, 41. PMID 15573802 |
0.697 |
|
2004 |
Mullins CD, Shaya FT, Flowers LR, Saunders E, Johnson W, Wong W. Health care cost of analgesic use in hypertensive patients. Clinical Therapeutics. 26: 285-93. PMID 15038951 DOI: 10.1016/S0149-2918(04)90027-6 |
0.337 |
|
Show low-probability matches. |